questionsmedicales.fr
Maladies du système stomatognathique
Maladies de la bouche
Noma
Noma : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Diagnostic différentiel
Noma
Complications
5
Infections secondaires
Noma
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Noma : Questions médicales les plus fréquentes",
"headline": "Noma : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Noma : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-26",
"dateModified": "2025-04-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Noma"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies de la bouche",
"url": "https://questionsmedicales.fr/mesh/D009059",
"about": {
"@type": "MedicalCondition",
"name": "Maladies de la bouche",
"code": {
"@type": "MedicalCode",
"code": "D009059",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C07.465"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Noma",
"alternateName": "Noma",
"code": {
"@type": "MedicalCode",
"code": "D009625",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Elise Farley",
"url": "https://questionsmedicales.fr/author/Elise%20Farley",
"affiliation": {
"@type": "Organization",
"name": "Noma Children's Hospital, Médecins Sans Frontières, Sokoto, Nigeria."
}
},
{
"@type": "Person",
"name": "Tetsushi Ono",
"url": "https://questionsmedicales.fr/author/Tetsushi%20Ono",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Veterinary Medicine, Okayama University of Science, Ehime 794-8555, Japan."
}
},
{
"@type": "Person",
"name": "Eri Iwata",
"url": "https://questionsmedicales.fr/author/Eri%20Iwata",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Veterinary Medicine, Okayama University of Science, Ehime 794-8555, Japan."
}
},
{
"@type": "Person",
"name": "Emi Ohzawa",
"url": "https://questionsmedicales.fr/author/Emi%20Ohzawa",
"affiliation": {
"@type": "Organization",
"name": "Noma Horse Preservation Society, Ehime 794-0082, Japan."
}
},
{
"@type": "Person",
"name": "Hitoshi Kitagawa",
"url": "https://questionsmedicales.fr/author/Hitoshi%20Kitagawa",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Veterinary Medicine, Okayama University of Science, Ehime 794-8555, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "iPSC-derived type IV collagen α5-expressing kidney organoids model Alport syndrome.",
"datePublished": "2023-09-28",
"url": "https://questionsmedicales.fr/article/37770589",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s42003-023-05203-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Next-Generation Sequencing (NGS) Analysis Illustrates the Phenotypic Variability of Collagen Type IV Nephropathies.",
"datePublished": "2023-03-21",
"url": "https://questionsmedicales.fr/article/36981034",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/genes14030764"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dynamics of type IV collagen 7S fragment on eradication of HCV with direct antiviral agents: Prognostic and metabolomic impacts.",
"datePublished": "2022-10-27",
"url": "https://questionsmedicales.fr/article/36301899",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0276925"
}
},
{
"@type": "ScholarlyArticle",
"name": "A high-impact FN1 variant correlates with fibronectin-mediated glomerulopathy via decreased binding to collagen type IV.",
"datePublished": "2023-01-20",
"url": "https://questionsmedicales.fr/article/36774238",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.pathol.2022.10.016"
}
},
{
"@type": "ScholarlyArticle",
"name": "Collagen Type IV Alpha 5 Chain in Bronchiolitis Obliterans Syndrome After Lung Transplant: The First Evidence.",
"datePublished": "2023-07-04",
"url": "https://questionsmedicales.fr/article/37402896",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00408-023-00632-8"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système stomatognathique",
"item": "https://questionsmedicales.fr/mesh/D009057"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies de la bouche",
"item": "https://questionsmedicales.fr/mesh/D009059"
},
{
"@type": "ListItem",
"position": 4,
"name": "Noma",
"item": "https://questionsmedicales.fr/mesh/D009625"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Noma - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Noma",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-04-30",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Noma",
"description": "Comment diagnostiquer le noma ?\nQuels tests sont utilisés pour le noma ?\nLe noma est-il visible à l'examen physique ?\nQuels signes cliniques indiquent le noma ?\nLe noma peut-il être confondu avec d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D009625?mesh_terms=Collagen+Type+IV#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Noma",
"description": "Quels sont les symptômes du noma ?\nLe noma cause-t-il des douleurs ?\nY a-t-il des signes de malnutrition avec le noma ?\nLe noma entraîne-t-il une mauvaise haleine ?\nLe noma affecte-t-il l'appétit ?",
"url": "https://questionsmedicales.fr/mesh/D009625?mesh_terms=Collagen+Type+IV#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Noma",
"description": "Comment prévenir le noma ?\nL'éducation sanitaire aide-t-elle à prévenir le noma ?\nLes vaccinations préviennent-elles le noma ?\nLe suivi médical régulier est-il important ?\nLes programmes de nutrition peuvent-ils réduire le risque de noma ?",
"url": "https://questionsmedicales.fr/mesh/D009625?mesh_terms=Collagen+Type+IV#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Noma",
"description": "Comment traite-t-on le noma ?\nLes antibiotiques sont-ils efficaces contre le noma ?\nLa chirurgie est-elle nécessaire pour le noma ?\nLe traitement du noma nécessite-t-il une hospitalisation ?\nY a-t-il des traitements préventifs pour le noma ?",
"url": "https://questionsmedicales.fr/mesh/D009625?mesh_terms=Collagen+Type+IV#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Noma",
"description": "Quelles sont les complications du noma ?\nLe noma peut-il entraîner des problèmes psychologiques ?\nLe noma peut-il affecter la croissance des enfants ?\nY a-t-il un risque de récidive du noma ?\nLe noma peut-il causer des infections secondaires ?",
"url": "https://questionsmedicales.fr/mesh/D009625?mesh_terms=Collagen+Type+IV#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Noma",
"description": "Quels sont les facteurs de risque du noma ?\nLa malnutrition est-elle un facteur de risque pour le noma ?\nLes enfants sont-ils plus à risque de noma ?\nLes maladies chroniques augmentent-elles le risque de noma ?\nLe manque d'hygiène buccale est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D009625?mesh_terms=Collagen+Type+IV#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer le noma ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et l'historique médical du patient."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le noma ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des prélèvements de tissus et des analyses sanguines peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Le noma est-il visible à l'examen physique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il se manifeste par des ulcérations et des déformations faciales."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent le noma ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des lésions buccales, une douleur intense et une mauvaise haleine sont des signes."
}
},
{
"@type": "Question",
"name": "Le noma peut-il être confondu avec d'autres maladies ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec d'autres infections buccales ou faciales."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes du noma ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des ulcérations, une douleur faciale et une fièvre."
}
},
{
"@type": "Question",
"name": "Le noma cause-t-il des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il provoque des douleurs intenses dans la région affectée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes de malnutrition avec le noma ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le noma est souvent associé à une malnutrition sévère chez les enfants."
}
},
{
"@type": "Question",
"name": "Le noma entraîne-t-il une mauvaise haleine ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une mauvaise haleine est fréquente en raison des lésions buccales."
}
},
{
"@type": "Question",
"name": "Le noma affecte-t-il l'appétit ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur et les lésions peuvent réduire l'appétit du patient."
}
},
{
"@type": "Question",
"name": "Comment prévenir le noma ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut une nutrition adéquate et l'accès aux soins de santé."
}
},
{
"@type": "Question",
"name": "L'éducation sanitaire aide-t-elle à prévenir le noma ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation sur l'hygiène buccale et la nutrition est cruciale."
}
},
{
"@type": "Question",
"name": "Les vaccinations préviennent-elles le noma ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de vaccin spécifique contre le noma, mais la vaccination aide à prévenir d'autres infections."
}
},
{
"@type": "Question",
"name": "Le suivi médical régulier est-il important ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi médical peut aider à détecter précocement les problèmes de santé."
}
},
{
"@type": "Question",
"name": "Les programmes de nutrition peuvent-ils réduire le risque de noma ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des programmes de nutrition ciblés peuvent diminuer le risque de noma chez les enfants."
}
},
{
"@type": "Question",
"name": "Comment traite-t-on le noma ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut des antibiotiques, des soins locaux et parfois une chirurgie."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre le noma ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antibiotiques sont essentiels pour contrôler l'infection."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle nécessaire pour le noma ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, une intervention chirurgicale peut être nécessaire pour réparer les tissus."
}
},
{
"@type": "Question",
"name": "Le traitement du noma nécessite-t-il une hospitalisation ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une hospitalisation est souvent nécessaire pour un traitement intensif."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements préventifs pour le noma ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par une bonne nutrition et des soins bucco-dentaires."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du noma ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des déformations faciales, des infections systémiques et la mort."
}
},
{
"@type": "Question",
"name": "Le noma peut-il entraîner des problèmes psychologiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les déformations faciales peuvent causer des problèmes d'estime de soi et d'anxiété."
}
},
{
"@type": "Question",
"name": "Le noma peut-il affecter la croissance des enfants ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la malnutrition et l'infection peuvent entraver la croissance normale."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de récidive du noma ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement adéquat et prévention, le noma peut récidiver."
}
},
{
"@type": "Question",
"name": "Le noma peut-il causer des infections secondaires ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'infection peut se propager et entraîner des infections secondaires graves."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du noma ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent la malnutrition, l'immunodépression et le manque d'accès aux soins."
}
},
{
"@type": "Question",
"name": "La malnutrition est-elle un facteur de risque pour le noma ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la malnutrition est le principal facteur de risque pour développer le noma."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque de noma ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le noma touche principalement les enfants, surtout ceux en situation de précarité."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque de noma ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies chroniques qui affaiblissent le système immunitaire augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le manque d'hygiène buccale est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une mauvaise hygiène buccale peut favoriser l'apparition du noma."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/04/2025
Contenu vérifié selon les dernières recommandations médicales
6 publications dans cette catégorie
Affiliations :
Noma Children's Hospital, Médecins Sans Frontières, Sokoto, Nigeria.
Department of Public Health Medicine, University of Cape Town, Cape Town, Western Cape, South Africa.
5 publications dans cette catégorie
Affiliations :
Faculty of Veterinary Medicine, Okayama University of Science, Ehime 794-8555, Japan.
Publications dans "Noma" :
5 publications dans cette catégorie
Affiliations :
Faculty of Veterinary Medicine, Okayama University of Science, Ehime 794-8555, Japan.
Publications dans "Noma" :
5 publications dans cette catégorie
Affiliations :
Noma Horse Preservation Society, Ehime 794-0082, Japan.
Publications dans "Noma" :
5 publications dans cette catégorie
Affiliations :
Faculty of Veterinary Medicine, Okayama University of Science, Ehime 794-8555, Japan.
Publications dans "Noma" :
4 publications dans cette catégorie
Affiliations :
School of Global Health & Bioethics, Euclid University, Banjul, Gambia. Electronic address: gezahegn.heron@gmail.com.
Publications dans "Noma" :
4 publications dans cette catégorie
Affiliations :
Operational Center Amsterdam Headquarters, Médecins Sans Frontières, Amsterdam, The Netherlands.
Publications dans "Noma" :
4 publications dans cette catégorie
Affiliations :
Operational Center Amsterdam Headquarters, Médecins Sans Frontières, Amsterdam, The Netherlands.
Department of Medical Microbiology, Radboudumc, Nijmegen, The Netherlands.
Publications dans "Noma" :
4 publications dans cette catégorie
Affiliations :
Faculty of Veterinary Medicine, Okayama University of Science, Ehime 794-8555, Japan.
Publications dans "Noma" :
4 publications dans cette catégorie
Affiliations :
Faculty of Veterinary Medicine, Okayama University of Science, 1-3 Ikoino-oka, Imabari, Ehime 794-8555, Japan.
Publications dans "Noma" :
3 publications dans cette catégorie
Affiliations :
Doctors Without Borders, Amsterdam, Holland. Noma Project, Sokoto, Nigeria.
Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology, Massachusetts Eye and Ear, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
Department of Global Health and Social Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
Department of Otolaryngology, University Teaching Hospital Kigali, University of Rwanda, College of Medicine & Health Sciences, Kigali, Rwanda.
Publications dans "Noma" :
3 publications dans cette catégorie
Affiliations :
Department of Oral Medicine and Periodontology, University of the Witwatersrand, Johannesburg, South Africa.
Publications dans "Noma" :
3 publications dans cette catégorie
Affiliations :
, 111 Portman Place, Fir Avenue, Bantry Bay, Cape Town, 8005, South Africa.
Publications dans "Noma" :
3 publications dans cette catégorie
Affiliations :
Operational Center Amsterdam Headquarters, Médecins Sans Frontières, Amsterdam, The Netherlands.
Publications dans "Noma" :
3 publications dans cette catégorie
Affiliations :
Nigeria Mission, Médecins Sans Frontières, Abuja, Nigeria.
Publications dans "Noma" :
3 publications dans cette catégorie
Affiliations :
Nigeria Mission, Médecins Sans Frontières, Abuja, Nigeria.
Publications dans "Noma" :
3 publications dans cette catégorie
Affiliations :
Service of Plastic, Reconstructive and Aesthetic Surgery, Geneva University Hospitals, Geneva, Switzerland.
Publications dans "Noma" :
3 publications dans cette catégorie
Affiliations :
Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, Western Cape, South Africa.
Publications dans "Noma" :
3 publications dans cette catégorie
Affiliations :
Faculty of Veterinary Medicine, Okayama University of Science, Ehime 794-8555, Japan.
Publications dans "Noma" :
3 publications dans cette catégorie
Affiliations :
Faculty of Veterinary Medicine, Okayama University of Science, Ehime 794-8555, Japan.
Publications dans "Noma" :
Alport syndrome (AS) is a hereditary glomerulonephritis caused by COL4A3, COL4A4 or COL4A5 gene mutations and characterized by abnormalities of glomerular basement membranes (GBMs). Due to a lack of c...
Liver fibrosis is one of the cardinal clinical features of chronic hepatitis C (CHC). However, the mechanisms underlying the evolution and reversion of liver fibrosis after hepatitis C virus (HCV) era...
Between October 2014 and September 2019, 418 patients with CHC or compensated cirrhosis with HCV were prospectively recruited in this observational study. 326 patients that were successfully eradicate...
Ten (3.1%) patients died during the observation period. 4COL7S-defined fibrosis progression (n = 97, 29.8%) at SVR was significantly correlated with worse all-cause mortality post-SVR (P = 0.0062) but...
Peri-treatment dynamics of serum 4COL7S, a non-invasive fibrosis marker, predict prognosis. Non-invasive fibrosis markers may be useful biomarkers for risk stratification post-SVR....
The glomerular basement membrane (GBM) consists of laminins, collagen IV, nidogens, and fibronectin and is essential for filtration barrier integrity in the kidney. Critically, structural and function...
Bronchiolitis obliterans syndrome (BOS) is the most common form of CLAD and is characterized by airflow limitation and an obstructive spirometry pattern without parenchymal opacities. The protein sign...
41 patients who had undergone LTX were enrolled. Of these, 27 developed BOS and 14 (control group) were considered stable at the time of serum sampling. Of BOS patients, serum samples were analysed at...
Serum concentrations of COL4A5 were higher in pre-BOS than in stable patients (40.5 ± 13.9 and 24.8 ± 11.4, respectively, p = 0.048). This protein is not influenced by comorbidities, such as acute rej...
Serum concentrations of COL4A5 can be considered a good prognostic marker due to their association with survival and correlation with functional parameters....
Children with persistent, isolated microscopic hematuria typically undergo a limited diagnostic workup and are monitored for signs of kidney disease in long-term longitudinal follow-up, which can dela...
To determine the clinical utility of genetic screening in this population, we performed targeted genetic testing using a custom, 32-gene next-generation sequencing panel for progressive kidney disease...
In cohort 1 33% of subjects (10/30) had pathogenic or likely pathogenic (P/LP) variants in the type IV collagen genes (COL4A3/A4/A5), and 10% (3/30) had variants of uncertain significance in these gen...
Children with persistent, isolated microscopic hematuria have a high likelihood of having pathogenic variants in type IV collagen genes and genetic screening should be considered. A higher resolution ...
The objective of this study was to develop a serum biochemical marker of the degradation of type III and IV collagens, as an index of synovium turnover, and evaluate its performance in patients with r...
Increased collagen remodelling is a key pathophysiological component underlying intestinal stricture and fistula development in Crohn's disease (CD)....
To investigate associations between serological biomarkers of collagen turnover and disease behaviour according to the Montreal classification in patients with CD....
Serological biomarkers of type III/IV collagen formation (PRO-C3, PRO-C4) and matrix metalloproteinase (MMP) or granzyme-B (GrzB)-mediated type I, III, IV and VI collagen degradation (C1M, C3M, C4M, C...
C1M, C3M and C4M were significantly reduced in patients with stricturing disease (Montreal B2) and accurately differentiated them from patients with either non-stricturing, non-penetrating (B1) or pen...
Elevated degradation of type I, III and IV collagen and excessive (relative) formation of type IV collagen strongly associates with stricturing CD. Type I and IV collagen fragments show predictive pot...
Escherichia coli (E. coli) is one of the main bacteria associated with preterm premature rupture of membranes by increasing pro-matrix metalloproteinase 9 (proMMP-9) and degradation of type IV collage...
Nine HFMi were mounted in a Transwell system. MDec was stimulated with P4 or E. coli for 3-, 6-, or 24-hours. proMMP-2, -9 and type IV collagen were assessed....
Gelatin zymography revealed an increase in proMMP-9 after 3, 6, and 24 h of stimulating MDec with E. coli. Using immunofluorescence, it was confirmed the increase in the HFMi tissue and a reduction on...
P4 modulates the activity of proMMP-9 induced by E. coli stimulation but it was unable to completely reverse the degradation of type IV collagen in human MDec tissue....
X-linked Alport syndrome is a genetic kidney disease caused by pathogenic COL4A5 variants, but little is known of the consequences of missense variants affecting the NC1 domain of the corresponding co...